drugset / Trial / NCT01560546

Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)

NCT01560546

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, placebo-controlled, double-blinded study on 40 men with type 2 DM. Type 2 diabetes mellitus (T2DM) is a common endocrine disorder characterized by hyperinsulinaemia and insulin resistance. Hypothesis Testosterone therapy increases lean body mass and insulin sensitivity in men with low normal levels of bioavailable testosterone and type 2 DM.

Timeline

Start
2012-03
Primary completion
2013-05
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 50 mg